Why Has PepGen Stock (PEPG) Increased by 125% Today?
PEPGEN Stock Rises After Positive Trial Results PEPGEN (PEPG) saw a significant boost in its stock value on Thursday, following the release of results from a Phase 1 clinical trial. This research focused on PGN-EDODM1 as a potential treatment for myotonic dystrophy type 1, which is a genetic muscle disorder leading to progressive weakness and […]